Plaintiffs Seek Preliminary Approval of $1.51 Billion Settlement With Syngenta

Ridgefield Park, N.J. – Today plaintiffs, in the litigation against Syngenta related to its marketing and commercialization of Agrisure Viptera and Agrisure Duracade corn seeds, filed a motion for preliminary approval of a settlement with Syngenta before the United States District Court in the District of Kansas (MDL no. 2591). The settlement with Syngenta was reached in September of 2017 […]

March 12, 2018

Settlement With Syngenta

Ridgefield Park, N.J. – Today plaintiffs, in the litigation against Syngenta related to its marketing and commercialization of Agrisure Viptera and Agrisure Duracade corn seeds, filed a motion for preliminary approval of a settlement with Syngenta before the United States District Court in the District of Kansas (MDL no. 2591).

The settlement with Syngenta was reached in September of 2017 and finalized on February 23, 2018. The terms of the settlement were agreed upon only after years of hard fought litigation and negotiations between Syngenta and various plaintiff groups. If the settlement is approved, Syngenta will contribute $1.51 billion dollars to a settlement fund that would be used to make payments to be allocated among eligible corn farmers, grain handling facilities and ethanol production facilities who fall within the settlement class and to cover the costs of administering the settlement, including any court-approved award of fees to plaintiffs’ counsel, in exchange for a classwide release of all claims against Syngenta related to the launch of Agrisure Viptera and Agrisure Duracade. The $1.51 billion dollar settlement will resolve thousands of pending cases against Syngenta. The settlement does not constitute an admission by either side concerning the merits of the parties’ allegations and defenses.

If preliminary approval is granted, plaintiffs’ lawyers will begin notifying potential claimants about the settlement and how to submit a claim for compensation. The amount received by any individual claimant will vary depending on the individual claimant’s farming, grain handling, or ethanol production operations and will be determined through a claims process.

Plaintiffs are pleased with the settlement and look forward to the Court granting preliminary approval so next steps can be communicated to corn farmers and others eligible for compensation.

Seeger Weiss partner Chris Seeger served as a court-appointed member of the Plaintiffs’ Settlement Committee and Stephen Weiss served as a member of the Plaintiffs’ Executive Committee. Seeger and Weiss were accompanied in their efforts by partner Dion Kekatos, who was centrally involved in the multidistrict litigation and settlement briefing.

Notwithstanding claims relating to this product, the drug/medical device remains approved by the U.S. FDA.

Read the full press release here.

Related News

September 22, 2023
Seeger Weiss Represents City of Chicago in New PCB Lawsuit Against Monsanto

Earlier this week, the City of Chicago filed a lawsuit against Monsanto and other chemical companies seeking damages for widespread contamination of its waterways caused by Polychlorinated biphenyls (PCBs), highly toxic and dangerous chemical compounds known to accumulate in the human body and cause serious health effects. Plaintiffs allege that Monsanto intentionally misled the public […]

Read More
September 15, 2023
Seeger Weiss Files First Lead Cable Class Action Lawsuit against Verizon

Seeger Weiss filed the first class action lawsuit against Verizon on behalf of utility workers over the company’s toxic lead-sheathed cables. Plaintiffs allege that Verizon knowingly left lead cables in place, exposing thousands of utility workers directly to dangerous levels of lead and allowing the cables to contaminate the surrounding environment. “For decades, Verizon and […]

Read More
September 7, 2023
Seeger Weiss Announces Settlement with Philips to Resolve Economic Loss Claims for Recalled CPAPs, Bi-PAPs, And Ventilators

Today, Seeger Weiss founding partner Chris Seeger, who serves as co-lead counsel in the Philips Recalled CPAP, Bi-Level Pap, and Mechanical Ventilator Products Litigation, announced a settlement worth a minimum of $479M on behalf of device users who purchased or rented recalled devices and payers who reimbursed users for the cost of recalled devices. “This […]

Read More